Linear Clinical Research Current Trials Menu

LE17124 | Hearing Loss Study

On Hold

Investigating a new treatment for children with cancer who suffer hearing loss as a result of exposure to chemotherapy drugs. It is estimated that, on average, about 750 children aged 0-14 years old are diagnosed with cancer each year in Australia (Cancer Council). Participating in this trial means you’ll be supporting world leading research into improving hearing loss treatments for these children.

You Get $2320! 

(This payment is based on completing the in-house stay and all scheduled appointments)



Visit Schedule

2 nights and 3 days with one follow up phone call and three in-house follow-up appointments




COH 2.1 COH 2.2 COH 2.3 COH 2.4
In-House Check-In 20-Jan 30-Jan 03-Feb 10-Feb
Check-Out 22-Jan 01-Feb 05-Feb 12-Feb
Follow Up Day 4 (phone call) 24-Jan 03-Feb 07-Feb 14-Feb
Day 8 28-Jan 07-Feb 11-Feb 18-Feb
Day 15 04-Feb 14-Feb 18-Feb 25-Feb
Day 30 19-Feb 01-Mar 05-Mar 12-Mar

ReviewsVolunteer FAQsRefer a FriendSpeak to us on the PhoneOther trials

Inclusion Criteria

  • Healthy Males and Females, aged between 18 and 65
  • Body Mass Index (BMI) between 18 – 35 kg/m2
  • Normal hearing,  defined as ≤20 dB from 250 Hz to 8 kHz bilateral
  • No allergies to any local anesthetics (numbing medication)
  • Free from any clinically significant illness or disease as determined by their medical history.
  • Must be willing to attend a hearing test if eligible after first screening visit.


Find out now if you’re eligible by answering our pre-screening questions below.